Implementation of circulating tumor DNA (ctDNA) testing in precision oncology: A four-year experience from a tertiary cancer center in India
Study underscores substantial increase in the adoption of liquid biopsy and the real-world utility of ctDNA-based NGS testing in solid tumors contributing to improved patient care management.
Authors
- Prarthna Shah
- Sonam Hatkar
- Trupti Pai (ORCID: https://orcid.org/0000-0001-5160-3897)
- Omshree Shetty (ORCID: https://orcid.org/0000-0003-1996-4347)
- Mamta Gurav (ORCID: https://orcid.org/0000-0002-8618-6314)
- Shyam Pyari Jaiswar (ORCID: https://orcid.org/0000-0003-3931-9572)
- Ramya Iyer
- Nupur Karnik
- Prachi Gogte
- Ujwal Shetty (ORCID: https://orcid.org/0000-0002-7707-8186)
- Aruna Nair (ORCID: https://orcid.org/0000-0002-6011-737X)
- Gauri Deshpande (ORCID: https://orcid.org/0000-0002-9895-2995)
- Shambhavi Singh (ORCID: https://orcid.org/0009-0000-4489-1464)
- Aditi Arora
- Pradnya Joshi
- Sangeeta Desai
- Marilyn Mulay
- Tanuja Shet
- Prachi Pawar (ORCID: https://orcid.org/0009-0000-6520-2154)
- Archita Juneja
Institutions
- Homi Bhabha National Institute (IN)
- Sir H.N. Reliance Foundation Hospital and Research Centre (IN)
Publication Details
- Journal
- The Journal of Liquid Biopsy
- Published
- 2025-07-26
- DOI
- https://doi.org/10.1016/j.jlb.2025.100319
- Citations
- 2
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.87